The Patent Finder

MediBeacon Inc.

52 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
17
Ending by 2030
Jun 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 13, 2026
    The maintenance fee for Method for preparing and analyzing fluorescent compounds in plasma (US 11,674,965) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
  • 1 fee due Jan 25, 2027
    The maintenance fee for Anodic oxidation of 5-aminouracil (US 11,708,336) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
  • 2 fees due Jul 5 to 7, 2027 · next Jul 5
  • 1 fee due Aug 4, 2027
    The maintenance fee for Method for Non-Invasive Monitoring of Fluorescent Tracer Agent with Diffuse Reflection Corrections (US 10,548,521) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
  • 1 fee due Sep 15, 2027
    The maintenance fee for Methods of Using Optical Agents (US 9,283,288) comes due Sep 15, 2027. Unpaid by Mar 15, 2028, it lapses early.
  • 2 fees due Oct 9 to 30, 2027 · next Oct 9

Which patents, and when each one lapses · Pro

Recent changes

  • 3 terms have ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,115,000Pyrazine Derivatives and Uses Thereof in Renal Monitoring
In force
 · High confidence
In forceHigh confidence
US 9,216,963Pyrazine Derivatives with Extended Conjugation and Methods of Using the same in Optical Applications
In force
 · High confidence
In forceHigh confidence
US 10,370,362Pyrazine Derivatives with Extended Conjugation and Methods of Using the Same in Optical Applications
In force
 · High confidence
In forceHigh confidence
US 11,185,597Process for Using Optical Agents
In force
 · High confidence
In forceHigh confidence
US 8,697,871Integrated photoactive agents and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,283,288Methods of Using Optical Agents
In force
 · High confidence
In forceHigh confidence
US 8,350,032Integrated Photoactive Agents for Real-Time Monitoring of Hemostasis
In force
 · High confidence
In forceHigh confidence
US 8,481,734Pyrazine Derivatives and Uses Thereof, Including in Medical Imaging and Visualization Applications
In force
 · Medium confidence
In forceMedium confidence
US 8,313,729Integrated Photoactive Small Molecules and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,765,354Transcutaneous Organ Function Measurement
In force
 · High confidence
In forceHigh confidence
10 of 52 patents shown.
Pro members see all 52.
Pro members: see all 52 patents
Also on record, not counted in the 52: 5 lapsed for an unpaid fee · 16 ended at full term · 2 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 3 abandoned · 5 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited